Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

China · Delayed Price · Currency is CNY

54.10

+2.39 (4.62%)

At close: Jul 1, 2026

-16.55% (1Y)

Market Cap	4.39B -14.8%
Revenue (ttm)	605.58M -7.4%
Net Income	222.26M -25.1%
EPS	2.76 -24.9%
Shares Out	81.10M
PE Ratio	19.57
Forward PE	n/a
Dividend	1.04 (2.01%)
Ex-Dividend Date	Jun 17, 2026

Volume	575,870
Open	52.00
Previous Close	51.71
Day's Range	51.15 - 54.50
52-Week Range	49.00 - 88.96
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generat... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2010

Employees 807

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688581

Full Company Profile

Financial Performance

In 2025, Hangzhou AGS MedTech's revenue was 593.74 million, a decrease of -6.74% compared to the previous year's 636.63 million. Earnings were 221.71 million, a decrease of -24.43%.

Financial Statements